Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study.
Journal
CMAJ open
ISSN: 2291-0026
Titre abrégé: CMAJ Open
Pays: Canada
ID NLM: 101620603
Informations de publication
Date de publication:
Historique:
entrez:
26
9
2019
pubmed:
26
9
2019
medline:
26
9
2019
Statut:
epublish
Résumé
Opioids are an important pain therapy, but their use may be associated with adverse events in frail and cognitively impaired long-term care residents. The objective of this study was to investigate trends in opioid prescribing among Ontario long-term care residents over time, given the paucity of data for this setting. We used linked clinical and health administrative databases to conduct a population-based, repeated cross-sectional study of opioid use among Ontario long-term care residents between Apr. 1, 2009, and Mar. 31, 2017. We identified prevalent opioid use by drug type, dosage and coprescription with benzodiazepines, and within certain vulnerable subgroups. We used log-binomial regression to quantify the percent change between 2009/10 and 2016/17. Among an average of 76 147 long-term care residents per year, the prevalence of opioid use increased from 15.8% in 2009/10 to 19.6% in 2016/17 ( Within Ontario long-term care, trends suggest a shift toward increased use of hydromorphone but reduced prevalence of use of other opioid agents and potentially inappropriate opioid prescribing. Further investigation is needed on the impact of these trends on resident outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Opioids are an important pain therapy, but their use may be associated with adverse events in frail and cognitively impaired long-term care residents. The objective of this study was to investigate trends in opioid prescribing among Ontario long-term care residents over time, given the paucity of data for this setting.
METHODS
METHODS
We used linked clinical and health administrative databases to conduct a population-based, repeated cross-sectional study of opioid use among Ontario long-term care residents between Apr. 1, 2009, and Mar. 31, 2017. We identified prevalent opioid use by drug type, dosage and coprescription with benzodiazepines, and within certain vulnerable subgroups. We used log-binomial regression to quantify the percent change between 2009/10 and 2016/17.
RESULTS
RESULTS
Among an average of 76 147 long-term care residents per year, the prevalence of opioid use increased from 15.8% in 2009/10 to 19.6% in 2016/17 (
INTERPRETATION
CONCLUSIONS
Within Ontario long-term care, trends suggest a shift toward increased use of hydromorphone but reduced prevalence of use of other opioid agents and potentially inappropriate opioid prescribing. Further investigation is needed on the impact of these trends on resident outcomes.
Identifiants
pubmed: 31551235
pii: 7/3/E582
doi: 10.9778/cmajo.20190052
pmc: PMC6759016
doi:
Types de publication
Journal Article
Langues
eng
Pagination
E582-E589Informations de copyright
Copyright 2019, Joule Inc. or its licensors.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Health Serv Res. 2005 Aug;40(4):1197-216
pubmed: 16033500
Drugs Aging. 2018 Jun;35(6):545-558
pubmed: 29725986
J Am Med Dir Assoc. 2018 Nov;19(11):959-966.e4
pubmed: 30262440
Age Ageing. 2016 Jan;45(1):54-60
pubmed: 26764395
J Am Geriatr Soc. 2017 Sep;65(9):2044-2051
pubmed: 28791683
Drugs Aging. 2016 Jul;33(7):523-33
pubmed: 27241038
Physiother Can. 2010 Spring;62(2):104-13
pubmed: 21359040
Curr Clin Pharmacol. 2015;10(3):194-203
pubmed: 26338172
Can Fam Physician. 2011 Nov;57(11):1269-76, e419-28
pubmed: 22084456
Clin Interv Aging. 2018 May 16;13:935-946
pubmed: 29805252
BMJ. 2011 Jul 15;343:d4065
pubmed: 21765198
BMC Geriatr. 2016 Jul 07;16:133
pubmed: 27388294
BMC Med Inform Decis Mak. 2013 Feb 26;13:27
pubmed: 23442258
CMAJ. 2018 Apr 23;190(16):E500-E506
pubmed: 29685910
Pain Med. 2019 Jan 1;20(1):50-57
pubmed: 29136228
CMAJ Open. 2017 Nov 22;5(4):E800-E807
pubmed: 29167237
J Am Geriatr Soc. 2004 Jun;52(6):867-74
pubmed: 15161448
Stat Med. 1994 Jun 15;13(11):1149-63
pubmed: 8091041
CMAJ. 2017 Jun 26;189(25):E851-E860
pubmed: 28652480
Int J Geriatr Psychiatry. 2015 Jan;30(1):55-63
pubmed: 24733695
J Am Med Dir Assoc. 2015 Nov 1;16(11):973-8
pubmed: 26170037
J Am Geriatr Soc. 2017 Oct;65(10):2205-2212
pubmed: 28752589
Br J Clin Pharmacol. 2011 Mar;71(3):351-64
pubmed: 21284694
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):281-5
pubmed: 15031314
CMAJ Open. 2014 Oct 01;2(4):E256-61
pubmed: 25485251
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49
pubmed: 26987082
J Am Med Dir Assoc. 2012 May;13(4):344-9
pubmed: 21450246
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Am Geriatr Soc. 2017 Feb;65(2):286-293
pubmed: 28198563
Clin Interv Aging. 2013;8:1471-82
pubmed: 24204133
Int J Geriatr Psychiatry. 2016 Dec;31(12):1354-1370
pubmed: 26898542
BMC Health Serv Res. 2014 Jan 15;14:17
pubmed: 24423071
Clin Pharmacol Ther. 2003 Aug;74(2):102-12
pubmed: 12891220
BMJ. 2017 Mar 14;356:j760
pubmed: 28292769
BMC Geriatr. 2012 Sep 14;12:56
pubmed: 22978265
Pharmacotherapy. 2017 Sep;37(9):1105-1121
pubmed: 28699646
J Pharm Pract. 2014 Feb;27(1):5-16
pubmed: 24436437